In conclusion, our study emphasized that FGF21 could serve as a potential biomarker for the occurrence of RAO, but also highlighted the association between elevated FGF21 levels and worse visual outcomes and risk of concurrent ischemic stroke. This evidence concerns the gene FGF21 and ischemic stroke.